Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Reexamination Certificate
2006-06-13
2006-06-13
Jones, Dameron (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
C424S001110, C424S001650, C424S009100, C424S001890, C424S001850, C424S001810
Reexamination Certificate
active
07060251
ABSTRACT:
The invention provides imaging agents comprising a label in association with a plaque specific targeting molecule. Methods for using the imaging agents to diagnose or monitor plaque formation and growth and kits containing the cardiovascular agents or components suitable for production of the imaging agents are also provided.
REFERENCES:
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 5364612 (1994-11-01), Goldenberg
patent: 5744120 (1998-04-01), Edwards et al.
patent: 6025477 (2000-02-01), Calenoff
patent: 6299857 (2001-10-01), Elmaleh et al.
patent: 6331287 (2001-12-01), Conti et al.
patent: 0 419 203 (1991-03-01), None
patent: WO 90/10463 (1990-09-01), None
patent: WO 91/02547 (1991-03-01), None
patent: WO 93/12819 (1993-07-01), None
patent: WO 95/03280 (1995-02-01), None
patent: WO 95/06633 (1995-03-01), None
patent: WO 95/11045 (1995-04-01), None
patent: WO 96/31243 (1996-10-01), None
patent: WO 97/10853 (1997-03-01), None
Babich and Fischman; “Effect of “Co-Ligand” on the Biodistribution of99mTc-labeled Hydrazino Nicotinic Acid Derivatized Chemotactic Peptides”, Nucl. Med. Biol. 22(1): 25-30, (1995).
Dinkelborg et al.; “Molecular Imaging of Atherosclerosis Using a Technetium-99m-Labeled Endothelin Derivative”, J. Nucl. Med. 39: 1819-1822, (1998).
Hom and Katzenellenbogen; “Technetium-99m-Labeled Receptor-Specific Small -Molecular Radiopharmaceuticals: Recent Developments and Encouraging Results”, Nuclear Medicine & Biology 24: 485-498, (1997).
Liu et al; “99m Tc-labeling Kinetics of Four Thiol-Countaining Chelators and 2-Hydrazinopyridine: Factors Influencing Their Radiolabeling Efficiency”, Appl. Radiat. Isot. 48(8): 1103-1111, ( 1997).
Mahmood et al., “A New Approach To Labeling Cells With Technetium-99m, Part I. Preparation of Modified Polylysine and In Vitro Cell Labeling”, Nuclear Medicine and Biology 23: 79-85, (1996).
Vaidyananathan and Zalutsky; “Fluorine-18 Labeled Chemotactic Peptides: A Potential Approach for the PET Imaging of Bacterial Infection”, Nuclear Medicine and Biology, 22 (6): 759-764, ( 1995).
Welling et al.; “Detection of Experimental Infections with99mTc-Labeled Monoclonal Antibodies Against TNF-α AND Interleukin-8”, Nuclear Medicine & Biology 24: 649-655, (1997).
International Search Report Completed on Jan. 13, 1999 and Mailed on Feb. 1, 1999.
Babich John W.
Elmaleh David R.
Fischman Alan J.
Foley & Hoag LLP
Jones Dameron
The General Hospital Corporation
LandOfFree
Imaging agents for early detection and monitoring of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imaging agents for early detection and monitoring of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging agents for early detection and monitoring of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3622168